Utility of the serum C-reactive protein for detection of occult bacterial infection in children

Archives of Pediatrics and Adolescent Medicine

Volumn 156, Issue 9, 2002, Pages 905-909

  Isaacman, Daniel J ^a   Burke, Bonnie L ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD CELL COUNT; BLOOD CULTURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY WARD; EVALUATION; FEVER; HUMAN; INFANT; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NEUTROPHIL; PEDIATRIC HOSPITAL; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; URINARY TRACT INFECTION;

EID: 0036766699     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.156.9.905     Document Type: Article

References (18)

1. Alpern ER, Alesandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection and outcome. Pediatrics. 2000;106:505-511.
2. Fleisher GR, Rosenberg N, Vinci R, et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr. 1994:504-512.
3. Jaffe DM, Tanz RR, Davis AT, Henretig F, Fleisher G. Antibiotic administration to treat possible occult bacteremia in febrile children. N Engl J Med. 1987;317:1175-1180.
4. Lee GM, Harper MB. Risk of bacteremia in febrile young children in the postHaemophilus influenzae type b era. Arch Pediatr Adolesc Med. 1998;152:624-628.
5. Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med. 1998;31:679-687.
6. Putto A, Ruuskanen O, Meurman O, et al. C-reactive protein in the evaluation of febrile illness. Arch Dis Child. 1986;61:24-29.,
7. De A, Saraswathi K, Gogate A, Raghavan K. C-reactive protein and buffy coat smear in early diagnosis of childhood septicemia. Indian J Pathol Microbiol. 1998;41:23-26.
8. Kohli V, Singhi S, Sharma P, Ganguly N. Value of C-reactive protein concentrations in febrile children without apparent focus. Ann Trop Paediatr. 1993;13:373-378.
9. Stanley T, Barrett D, Salmond CE. Viral and bacterial infection in childhood: the value of C-reactive protein. N Z Med J. 1991;104:138-139.
10. Gabay CEM, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
11. Jaye D, Waites K. Clinical application of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16:735-747.
12. Peltola H, Jaakkola M. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised hosts. J Pediatr. 1988;113:641-646.
13. Pulliam P, Attia M, Cronan K. C-reactive protein in febrile children 1-36 months of age with clinically undetectable serious bacterial infection. Pediatrics. 2001;108:1275-1280.
14. Lacour AG, Gervais A, Zamora SA, et al. Procacitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr. 2001;160:95-100.
15. Sormunen P, Kallio MJT, Kilpi T. C-reactive protein is useful in distinguishing gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr. 1999;134:724-729.
16. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0-36 months of age with fever without source. Pediatrics. 1993;92:1-12.
17. Isaacman DJ, Karasic RB. Lack of effect of changing needles on contamination of blood cultures. Pediatr Infect Dis J. 1990;9:274-278.
18. Lee GM, Fleisher GR, Harper M. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. 2001;108:835-844.